Innoviva (INVA) Amortizatization of Intangibles (2013 - 2026)
Innoviva posted quarterly Amortizatization of Intangibles of $6.6 million for Q1 2026, up 1.93% year-on-year from $6.5 million in Q1 2025, and little changed on a QoQ basis from $6.6 million in Q3 2025.
Innoviva (INVA) has 13 years of Amortizatization of Intangibles data on file, last reported at $6.6 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 1.93% year-over-year to $6.6 million; the trailing twelve-month figure through Mar 2026 stood at $26.2 million (up 1.55% YoY), and the FY2025 full-year result was $26.3 million, up 1.46% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $6.6 million, roughly flat from $6.6 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $6.6 million in Q3 2025 and bottomed at $1.5 million in Q3 2022.
- The 5-year median for Amortizatization of Intangibles is $6.5 million (2025), against an average of $5.7 million.
- The widest annual swing landed in 2023, when Amortizatization of Intangibles soared 330.18%; it then changed 0.0% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $1.5 million in 2022, then jumped by 330.18% to $6.5 million in 2023, then changed by 0.0% to $6.5 million in 2024, then gained by 1.54% to $6.6 million in 2025, then changed by 0.0% to $6.6 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $6.6 million (Q1 2026), $6.6 million (Q3 2025), and $6.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 6.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.60 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Sep 30, 2025 | 6.60 Mn |
| Sep 30, 2025 | 6.60 Mn |
| Jun 30, 2025 | 6.50 Mn |
| Jun 30, 2025 | 6.50 Mn |
| Mar 31, 2025 | 6.48 Mn |
| Mar 31, 2025 | 6.48 Mn |
| Sep 30, 2024 | 6.50 Mn |
| Sep 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 6.40 Mn |
| Jun 30, 2024 | 6.40 Mn |
| Mar 31, 2024 | 6.40 Mn |
| Mar 31, 2024 | 6.40 Mn |
| Sep 30, 2023 | 6.50 Mn |
| Sep 30, 2023 | 6.50 Mn |
| Jun 30, 2023 | 4.96 Mn |
| Jun 30, 2023 | 4.96 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Sep 30, 2022 | 1.51 Mn |
| Sep 30, 2022 | 1.51 Mn |
| Dec 31, 2020 | -343,000.00 |
| Dec 31, 2020 | -343,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Jun 30, 2020 | 64,000.00 |
| Jun 30, 2020 | 64,000.00 |
| Mar 31, 2020 | 272,000.00 |
| Mar 31, 2020 | 272,000.00 |
| Dec 31, 2019 | 490,000.00 |
| Dec 31, 2019 | 490,000.00 |
| Sep 30, 2019 | 615,000.00 |
| Sep 30, 2019 | 615,000.00 |
| Jun 30, 2019 | 768,000.00 |
| Jun 30, 2019 | 768,000.00 |
| Mar 31, 2019 | 356,000.00 |
| Mar 31, 2019 | 356,000.00 |
| Dec 31, 2018 | 32,000.00 |
| Dec 31, 2018 | 32,000.00 |
| Sep 30, 2018 | 64,000.00 |
| Sep 30, 2018 | 64,000.00 |
| Jun 30, 2018 | 60,000.00 |
| Jun 30, 2018 | 60,000.00 |
| Mar 31, 2018 | 100,000.00 |
| Mar 31, 2018 | 100,000.00 |
| Dec 31, 2017 | 99,000.00 |
| Dec 31, 2017 | 99,000.00 |
| Sep 30, 2017 | 12,000.00 |
| Sep 30, 2017 | 12,000.00 |
| Jun 30, 2017 | 11,000.00 |
| Jun 30, 2017 | 11,000.00 |
| Mar 31, 2017 | -17,000.00 |
| Mar 31, 2017 | -17,000.00 |
| Dec 31, 2016 | 1,000.00 |
| Dec 31, 2016 | 1,000.00 |
| Sep 30, 2016 | -6,000.00 |
| Sep 30, 2016 | -6,000.00 |
| Jun 30, 2016 | 11,000.00 |
| Jun 30, 2016 | 11,000.00 |
| Mar 31, 2016 | 3,000.00 |
| Mar 31, 2016 | 3,000.00 |
| Dec 31, 2015 | -57,000.00 |
| Dec 31, 2015 | -57,000.00 |
| Sep 30, 2015 | -918,000.00 |
| Sep 30, 2015 | -918,000.00 |
| Jun 30, 2015 | 159,000.00 |
| Jun 30, 2015 | 159,000.00 |
| Mar 31, 2015 | 233,000.00 |
| Mar 31, 2015 | 233,000.00 |
| Dec 31, 2014 | -3.28 Mn |
| Dec 31, 2014 | -3.28 Mn |
| Sep 30, 2014 | 127,000.00 |
| Sep 30, 2014 | 127,000.00 |
| Jun 30, 2014 | 650,000.00 |
| Jun 30, 2014 | 650,000.00 |
| Mar 31, 2014 | 762,000.00 |
| Mar 31, 2014 | 762,000.00 |
| Dec 31, 2013 | 861,000.00 |
| Dec 31, 2013 | 861,000.00 |
| Sep 30, 2013 | 1.08 Mn |
| Sep 30, 2013 | 1.08 Mn |